vs

Side-by-side financial comparison of CSW INDUSTRIALS, INC. (CSW) and Enhabit, Inc. (EHAB). Click either name above to swap in a different company.

Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $233.0M, roughly 1.2× CSW INDUSTRIALS, INC.). CSW INDUSTRIALS, INC. runs the higher net margin — 4.4% vs -14.3%, a 18.7% gap on every dollar of revenue. On growth, CSW INDUSTRIALS, INC. posted the faster year-over-year revenue change (20.3% vs 4.7%). CSW INDUSTRIALS, INC. produced more free cash flow last quarter ($22.7M vs $3.3M). Over the past eight quarters, CSW INDUSTRIALS, INC.'s revenue compounded faster (5.1% CAGR vs 1.5%).

Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.

CSW vs EHAB — Head-to-Head

Bigger by revenue
EHAB
EHAB
1.2× larger
EHAB
$270.4M
$233.0M
CSW
Growing faster (revenue YoY)
CSW
CSW
+15.6% gap
CSW
20.3%
4.7%
EHAB
Higher net margin
CSW
CSW
18.7% more per $
CSW
4.4%
-14.3%
EHAB
More free cash flow
CSW
CSW
$19.4M more FCF
CSW
$22.7M
$3.3M
EHAB
Faster 2-yr revenue CAGR
CSW
CSW
Annualised
CSW
5.1%
1.5%
EHAB

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CSW
CSW
EHAB
EHAB
Revenue
$233.0M
$270.4M
Net Profit
$10.3M
$-38.7M
Gross Margin
39.7%
Operating Margin
7.4%
-12.3%
Net Margin
4.4%
-14.3%
Revenue YoY
20.3%
4.7%
Net Profit YoY
-61.9%
15.9%
EPS (diluted)
$0.62
$-0.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSW
CSW
EHAB
EHAB
Q4 25
$233.0M
$270.4M
Q3 25
$277.0M
$263.6M
Q2 25
$263.6M
$266.1M
Q1 25
$230.5M
$259.9M
Q4 24
$193.6M
$258.2M
Q3 24
$227.9M
$253.6M
Q2 24
$226.2M
$260.6M
Q1 24
$210.9M
$262.4M
Net Profit
CSW
CSW
EHAB
EHAB
Q4 25
$10.3M
$-38.7M
Q3 25
$40.7M
$11.1M
Q2 25
$40.9M
$5.2M
Q1 25
$35.1M
$17.8M
Q4 24
$26.9M
$-46.0M
Q3 24
$36.1M
$-110.2M
Q2 24
$38.6M
$-200.0K
Q1 24
$31.8M
$200.0K
Gross Margin
CSW
CSW
EHAB
EHAB
Q4 25
39.7%
Q3 25
43.0%
Q2 25
43.8%
Q1 25
44.2%
Q4 24
41.4%
Q3 24
45.6%
Q2 24
47.5%
Q1 24
44.4%
Operating Margin
CSW
CSW
EHAB
EHAB
Q4 25
7.4%
-12.3%
Q3 25
20.5%
6.4%
Q2 25
20.8%
6.3%
Q1 25
19.5%
6.1%
Q4 24
15.3%
-16.0%
Q3 24
22.6%
-38.6%
Q2 24
24.3%
4.3%
Q1 24
21.0%
4.9%
Net Margin
CSW
CSW
EHAB
EHAB
Q4 25
4.4%
-14.3%
Q3 25
14.7%
4.2%
Q2 25
15.5%
2.0%
Q1 25
15.2%
6.8%
Q4 24
13.9%
-17.8%
Q3 24
15.8%
-43.5%
Q2 24
17.1%
-0.1%
Q1 24
15.1%
0.1%
EPS (diluted)
CSW
CSW
EHAB
EHAB
Q4 25
$0.62
$-0.76
Q3 25
$2.41
$0.22
Q2 25
$2.43
$0.10
Q1 25
$2.05
$0.35
Q4 24
$1.60
$-0.92
Q3 24
$2.26
$-2.20
Q2 24
$2.47
$0.00
Q1 24
$2.03
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSW
CSW
EHAB
EHAB
Cash + ST InvestmentsLiquidity on hand
$40.2M
$43.6M
Total DebtLower is stronger
$426.0M
Stockholders' EquityBook value
$1.1B
$534.0M
Total Assets
$2.3B
$1.2B
Debt / EquityLower = less leverage
0.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSW
CSW
EHAB
EHAB
Q4 25
$40.2M
$43.6M
Q3 25
$31.5M
$56.9M
Q2 25
$38.0M
$37.1M
Q1 25
$225.8M
$39.5M
Q4 24
$213.8M
$28.4M
Q3 24
$273.2M
$45.7M
Q2 24
$18.9M
$28.5M
Q1 24
$22.2M
$36.5M
Total Debt
CSW
CSW
EHAB
EHAB
Q4 25
$426.0M
Q3 25
$441.5M
Q2 25
$456.9M
Q1 25
$800.1M
$467.3M
Q4 24
$492.6M
Q3 24
$502.9M
Q2 24
$512.7M
Q1 24
$166.0M
$526.7M
Stockholders' Equity
CSW
CSW
EHAB
EHAB
Q4 25
$1.1B
$534.0M
Q3 25
$1.1B
$566.8M
Q2 25
$1.1B
$552.4M
Q1 25
$1.1B
$543.2M
Q4 24
$1.0B
$523.5M
Q3 24
$1.0B
$566.1M
Q2 24
$650.2M
$674.3M
Q1 24
$615.7M
$672.3M
Total Assets
CSW
CSW
EHAB
EHAB
Q4 25
$2.3B
$1.2B
Q3 25
$1.5B
$1.2B
Q2 25
$1.5B
$1.2B
Q1 25
$1.4B
$1.2B
Q4 24
$1.4B
$1.2B
Q3 24
$1.4B
$1.3B
Q2 24
$1.1B
$1.4B
Q1 24
$1.0B
$1.4B
Debt / Equity
CSW
CSW
EHAB
EHAB
Q4 25
0.80×
Q3 25
0.78×
Q2 25
0.83×
Q1 25
0.75×
0.86×
Q4 24
0.94×
Q3 24
0.89×
Q2 24
0.76×
Q1 24
0.27×
0.78×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSW
CSW
EHAB
EHAB
Operating Cash FlowLast quarter
$28.9M
$4.4M
Free Cash FlowOCF − Capex
$22.7M
$3.3M
FCF MarginFCF / Revenue
9.8%
1.2%
Capex IntensityCapex / Revenue
2.6%
0.4%
Cash ConversionOCF / Net Profit
2.81×
TTM Free Cash FlowTrailing 4 quarters
$162.0M
$65.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSW
CSW
EHAB
EHAB
Q4 25
$28.9M
$4.4M
Q3 25
$61.8M
$37.8M
Q2 25
$60.6M
$10.6M
Q1 25
$27.3M
$17.9M
Q4 24
$11.6M
$-4.1M
Q3 24
$66.8M
$28.4M
Q2 24
$62.7M
$9.6M
Q1 24
$22.4M
$17.3M
Free Cash Flow
CSW
CSW
EHAB
EHAB
Q4 25
$22.7M
$3.3M
Q3 25
$58.7M
$36.2M
Q2 25
$57.7M
$8.7M
Q1 25
$22.8M
$17.6M
Q4 24
$8.5M
$-4.7M
Q3 24
$61.3M
$27.7M
Q2 24
$59.6M
$8.9M
Q1 24
$17.5M
$15.5M
FCF Margin
CSW
CSW
EHAB
EHAB
Q4 25
9.8%
1.2%
Q3 25
21.2%
13.7%
Q2 25
21.9%
3.3%
Q1 25
9.9%
6.8%
Q4 24
4.4%
-1.8%
Q3 24
26.9%
10.9%
Q2 24
26.3%
3.4%
Q1 24
8.3%
5.9%
Capex Intensity
CSW
CSW
EHAB
EHAB
Q4 25
2.6%
0.4%
Q3 25
1.1%
0.6%
Q2 25
1.1%
0.7%
Q1 25
2.0%
0.1%
Q4 24
1.6%
0.2%
Q3 24
2.4%
0.3%
Q2 24
1.4%
0.3%
Q1 24
2.3%
0.7%
Cash Conversion
CSW
CSW
EHAB
EHAB
Q4 25
2.81×
Q3 25
1.52×
3.41×
Q2 25
1.48×
2.04×
Q1 25
0.78×
1.01×
Q4 24
0.43×
Q3 24
1.85×
Q2 24
1.62×
Q1 24
0.71×
86.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSW
CSW

Contractor Solutions Segment$166.3M71%
Specialized Reliability Solutions Segment$38.2M16%
Engineered Building Solutions Segment$28.5M12%

EHAB
EHAB

Third Party Payor Medicare$111.6M41%
Third Party Payor Medicare Advantage$67.5M25%
Hospice Segment$63.6M24%
Third Party Payor Managed Care$24.9M9%
Third Party Payor Medicaid$1.7M1%

Related Comparisons